Company Overview

NAME	epitoMAP Inc.
REPRESENTATIVE	Kenichi Masuda
ADDRESS	Sagamihara Incubation Center (SIC-2) 5-4-30 Nishihashimoto, Midori-ku, Sagamihara, Kanagawa
ESTABLISH	July 3rd, 2020
CAPITAL STOCK	¥100,000,000
SHAREHOLDERS	Kenichi Masuda and others
Major Business	①Research and Development of Synthetic Peptide Vaccines and Therapeutics (Humans,Veterinary) ②Research and Development of Immunotherapeutics (Humans,Veterinary) ③Research and Development of Vaccines and Therapeutics for Zoonosis

Corporate Philosophy

We will develop new prophylactics and therapeutics to eradicate zoonosis and diseases, contributing to medicine in animals and humans.

History

2013	Conceptualization of synthetic peptide
2013	Collaborative research with the Institute of Physical and Chemical Research (RIKEN) and the Animal Allergy Clinical Laboratories, Inc. (AACL)
2015 April	RIKEN Vaccine Innovation Laboratory established
2020 July	epitoMAP Inc. established

Corporate Profile

CEO / Veterinarian

KENICHI MASUDA

After working as a veterinary clinician, he had worked at the University of Tokyo and RIKEN, before setting up the AACL—a venture by RIKEN—to establish standard allergy tests for dogs and cats. At the same time, he led RIKEN’s Vaccine Innovation Laboratory.

1992

Bachelar of Veterinary Medical Science (BVSc) Graduation from Faculty of Agriculture, Veterinary Medicine, Kagoshima University.
1992

Employed veterinarian as a private animal hospital
1997

Master of Science (MS), Graduation from Graduate School of Veterinary Medicine, The University of Illinois
1999

Assistant Professor, Graduate School of Agricultural and Life Sciences, The University of Tokyo
2003

Ph.D. Graduation from Graduate School of Agricultural and Life, Sciences, The University of Tokyo.
2004

Research Scientist, Research Center of Allergy and Immunology (RCAI), The Institute of Physical and Chemical Research (RIKEN)
2006

Concurrent post as Visiting Fellow at the North Carolina State University’s College of Veterinary Medicine
2007

Founder and Chief Executive Officer, Animal Allergy Clinical Laboratories, Inc.
2015

Team Leader of Vaccine Innovation Laboratory, RIKEN Innovation Center
2020

Founder and Chief Executive Officer, epitoMAP Inc.

Executive Board Member

KATSUMI KOBAYASHI

With experience working at veterinary clinics and establishing 2 companies in ventures into the field of veterinary clinical tests, he has a thorough knowledge of the industry. He has a sufficient experience in veterinary products.

Director, AACL Inc.; Graduated from the International Christian University’s Faculty of Education’s Division of Natural Sciences

Executive Board Member

SHOICHI HASEGAWA

After working at a financial institution, he joined a venture capital and was assigned to support university & technology startup companies. He took part in the establishment of epitoMAP.

Director, AACL Inc.; Graduated from Keio University’s Faculty of Business and Commerce